Morepen Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,537.59

1,338.88

1,449.27

1,112.42

791.99

Operating profit

161.82

77.27

129.14

112.37

64.47

Interest

3.51

1.98

-7.37

1.79

1.97

Gross profit

170.88

81.05

146.74

122.36

71.92

EPS (Rs)

2.17

0.90

2.12

2.10

0.72

Other income

12.57

5.76

10.24

11.77

9.42

Stock adjustment

5.13

16.54

1.74

-41.98

-7.58

Raw material

883.31

781.41

797.13

617.93

413.22

Power and fuel

34.09

12.95

18.93

13.00

12.56

Employee expenses

160.28

146.19

150.00

123.20

98.07

Excise

-

-

-

-

-

Admin and selling expenses

99.15

11.80

77.95

44.09

35.75

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

193.82

292.72

274.38

243.81

175.50

Provisions made

-

-

-

-

-

Depreciation

21.90

18.01

21.19

28.11

34.43

Taxation

38.04

16.80

24.48

-

5.15

Net profit / loss

110.94

46.24

101.06

94.25

32.33

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

102.23

102.23

95.56

89.96

89.96

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

10.52

5.77

8.91

10.10

8.14

GPM (%)

11.02

6.03

10.05

10.88

8.97

NPM (%)

7.16

3.44

6.92

8.38

4.03